A hexanucleotide repeat expansion in the gene C9orf72 is the most common genetic cause of both amyotrophic lateral sclerosis and frontotemporal dementia.
Introduction
A non-coding hexanucleotide repeat expansion in C9orf72 is the most common genetic cause of both frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) [1, 2] . The mutation is a (GGGGCC) n expansion with unaffected individuals typically carrying fewer than 30 repeats, while patients harbour several hundreds to thousands [1] [2] [3] [4] . Affected individuals present clinically with either ALS, FTD, or both [1, 2, 5] and display TDP-43 pathology [1, 6] . (1) The expansion leads to reduced transcription of C9orf72, leading to haploinsufficiency ( Figure 1A ).
(2) Repeat-containing sense and antisense RNA transcripts accumulate and sequester RNA binding proteins ( Figure 1B) .
(3) Sense and antisense RNA are translated by repeat-associated, non-ATG initiated (RAN) translation into five, potentially toxic, repetitive dipeptide proteins (DPRs) ( Figure 1C ).
We will critically review newly developed cellular and animal C9FTD/ALS models and discuss the insight they provide into the role of each proposed mechanism in disease pathogenesis.
Loss of function
C9orf72 has three splice variants that either harbour the expansion in the first intron of the gene (variants 1 and 3) or the promoter (variant 2) [1] . Variant 1 comprises exons 1-5 and encodes a short protein isoform (222 amino acids: C9ORF72-S) while variants 2 and 3 encode the long isoform (481 amino acids: C9ORF72-L) [1, 7] .
Analysis of post mortem C9ALS/FTD brains showed reduced C9orf72 transcript [1, [8] [9] [10] [11] [12] [13] and reduced protein [7, 11, 14] . This may be a consequence of epigenetic silencing [8, 10, 15, 16] or abortive transcription [17] . Reduced C9orf72 levels in patients led to the suggestion that loss of normal C9orf72 function leads to pathogenesis. However, only a single sporadic ALS patient has ever been found to carry a mutation potentially capable of causing a heterozygous loss of function, and it is unclear if this mutation is causative of the disease state [18, 19] . Additionally, a patient homozygous for the repeat expansion had a similar clinical phenotype to heterozygote patients, rather than a much more severe phenotype typical of homozygous loss of function mutations [12] . Therefore the genetic evidence currently supports a gain of function rather than a loss of function mechanism as the primary cause of disease [20] .
However, loss of function models are providing evidence in favour of an important role for C9orf72 in cellular functions relevant to neuronal function, which suggests loss of function could contribute to the disease process.
C9orf72 is homologous to members of the DENN (differentially expressed in normal and neoplastic cells) domain containing protein family, and is predicted to be involved in membrane trafficking as a Rab guanine exchange factor [21] . C9ORF72-L forms a complex with SMCR8 and WDR41 [22] [23] [24] [25] [26] [27] and is involved in the induction of autophagy [22, 23, 25, 28, 29] , whilst C9ORF72-S is localised at the nuclear membrane in patient brain and has been suggested to be involved in nucleocytoplasmic transport [7] . Work in cell lines or primary rodent neuronal cultures has demonstrated that knockdown of C9orf72 is sufficient to induce P62-positive puncta [23, 28] , consistent with autophagic dysfunction, and one study has observed the mislocalisation of phosphorylated TDP-43 after C9orf72 knockdown [23] .
Several animal models have been produced in which the expression of genes orthologous to C9orf72 are reduced (Table 1, Figure 1D ). Knockout of the C. elegans ortholog of C9orf72 (ALFA-1) led to progressive age-related paralysis [30] . Injection of antisense morpholino oligonucleotides during zebrafish development led to altered axonal branching in larval motor neurons and an associated motor phenotype [9] .
Consistent with this finding, it was recently shown that C9orf72 regulates actin dynamics and axon growth in cultured motor neurons [14] .
Several groups have tested the effect of reduced expression of the mouse ortholog of C9orf72 (3110043O21Rik), either in a tissue-specific or ubiquitous manner (Table   1 ). The results of these studies are strikingly concordant; no overt neurodegeneration occurs in response to partial or complete loss of C9orf72 function. Furthermore, no mislocalisation of TDP-43 is observed [31] [32] [33] . These findings clearly suggest that loss of C9orf72 function is not sufficient to cause disease. Interestingly, however, whilst neuron-specific knockdown or knockout had no pathogenic effects [31, 34] , whole-genome knockout resulted in immune system phenotypes, including splenomegaly (enlarged spleen) and lymphandenomegaly (enlarged lymph nodes) [25, 33, [35] [36] [37] . These findings are particularly interesting given the increasing evidence supporting a role for the immune system in a wide range of neurodegenerative diseases [38] .
Gain of RNA and Protein Function

Gain of Function Pathologies
A typical feature of many repeat expansion diseases is the formation of RNA foci:
aggregates of RNA which are capable of sequestering RNA-binding proteins [39] . In C9ALS/FTD, repeat-expanded RNA is transcribed in both sense and antisense directions and forms both nuclear, and rarer, cytoplasmic sense and antisense RNA foci across multiple patient brain regions, and in patient derived cell lines ( Figure 1B ) [1, 34, [40] [41] [42] [43] [44] [45] [46] [47] [48] . Several studies have identified RNA-binding proteins (RBPs) sequestered by sense and antisense transcripts. Therefore reduced availability of these RBPs may play a role in the disease state (reviewed in [49] ).
In addition to the formation of RNA foci, sense and antisense expansion-containing RNA is also RAN translated in all three reading frames, producing five, potentially toxic dipeptide-repeat proteins (DPRs) [43, 50, 51] ( Figure 1C ). DPRs form p62positive, TDP43-negative inclusions, abundant in the neocortex, hippocampus and cerebellum [50] [51] [52] . Typically, poly-GA inclusions are the most abundant, followed by poly-GP and poly-GR, whilst poly-AP and poly-PR inclusions are rare [47, 53, 54] .
Pathological studies have examined DPR inclusions in C9FTD, C9ALS or C9FTD/ALS patients, and have not found consistent correlations between RAN protein pathology and clinical phenotype, TDP-43 pathology or neurodegeneration [52, 53, 55] . However, a recent study found that levels of soluble poly-GP in the cerebellum correlate positively with cognitive impairment [56] .
Pure GGGGCC repeat models
In order to determine whether a gain of function is sufficient to induce a disease phenotype, several groups have overexpressed GGGGCC repeats and demonstrated deleterious phenotypes in cell culture [45, [57] [58] [59] , C.elegans [60] , Zebrafish [45] , and Drosophila [58, [61] [62] [63] models, providing evidence that C9orf72 mutation associated toxic gain of function is sufficient to cause disease ( Figure 1E ).
Recently, several mouse models of C9orf72 expansions have been produced, either using overexpression of hexanucleotide repeats [64] , or integration of human bacterial artificial chromosomes (BACs) containing expanded hexanucleotide DNA [35, 37, 66, 67] (Table 2) . Whilst all studies demonstrated that expression of repeat-expanded RNA led to foci formation, and resulted in at least some DPR species, the resultant phenotypes of the various mouse models were markedly different.
Overexpression of 66 GGGGCC repeats using adeno-associated viruses (AAVs) led to accumulation of RNA foci, DPR and TDP-43 pathology as well as neuronal loss with cognitive and motor dysfunction [64] . Generation of BAC mice led variously to: no cognitive or motor abnormalities [65, 66] , hippocampus-related cognitive dysfunction [37] or either acute or progressive phenotypes marked by behavioural and motor abnormalities and reduced survival [67] . The discrepancies between these outcomes seem unlikely to be due to differences in the amount of 5' or 3' C9orf72 flanking sequence present in each BAC, as the BACs from phenotypic and nonphenotypic mice overlapped ( Table 2 ). It is notable that the different models were produced in different genetic backgrounds (Table 2) , which can strongly influence neurodegenerative phenotypes in mice [68] . Additionally, toxicity may be dependent [67] found that strong overexpression of relatively short repeat lengths to be toxic, whilst Jiang et al. (2016) [37] found that foci formation and DPR accumulation were positively correlated with repeat-expansion-containing RNA expression levels. It is thus possible that the required level of putatively toxic RNA or DPR species was not met in non-phenotypic mice.
Despite these differences, the fact that expression of hexanucleotide RNA can lead to behavioural and motor abnormalities underpinned by neurodegeneration, especially in a BAC context where expression is driven by the endogenous C9orf72 promoter, strongly suggests that a gain of function alone is sufficient to drive pathogenesis. It is notable that phenotypic mice either displayed TDP-43 inclusions [64, 67] or increased TDP-43 phosphorylation [37] , providing further evidence that neurodegeneration is driven primarily through a toxic gain of function leading to TDP-43 pathology.
RNA or Protein?
Whilst pure GGGGCC repeat expression models provide evidence of a toxic gain of function, they cannot distinguish whether toxicity is primarily mediated by RNA or DPRs, which has led to considerable debate in the field.
RNA-only models
In order to study the potential role of RNA toxicity in isolation, it is necessary to design models where GGGGCC repeat containing RNA is expressed whilst RAN translation is suppressed. GGGGCC repeat RNA (36 and 103 repeats) is toxic to Drosophila neurons when overexpressed. Conversely, when the repeats are interrupted by regularly interspersed stop codons in every reading frame RAN translation and toxic phenotypes are completely prevented, even when up to ~288 interrupted repeats are expressed [61, 69] . This suggests that DPRs are the major contributor to toxicity in Drosophila models of C9orf72. In concordance with this conclusion, overexpression of sense hexanucleotide RNA from the intron of a transgene in Drosophila is sufficient for the formation of numerous RNA foci but does not cause toxicity, because efficient splicing of intronic repeat RNA prevents its nuclear export and RAN translation [70] ( Figure 1F ).
Interestingly, in a BAC mouse model, the presence of multiple copies of short repeat lengths (29-36 repeats) produced only DPRs and not nuclear RNA foci, but TDP-43 pathology and neurodegenerative phenotypes were still observed [67] (Table 2) .
Together these results suggest that RNA foci are dispensable for the induction of disease pathogenesis in Drosophila and mice. However, it is difficult to rule out a possible toxic effect of RNA that does not form foci, or cytoplasmic RNA, a prospect that has recently been raised in iPSC-derived neurons [63] . phenotypes, suggesting that toxicity in this model is primarily driven by RNA [71] . It should be noted however, that poly-GR becomes detectable upon strong overexpression in these flies, suggesting that there may be poly-GR present at undetectable levels, which may contribute to the observed phenotypes in lower expressing flies. Additionally, it has been shown that expression of 42 GGGGCC repeats from the intron of a transgene is toxic to mouse primary cortical and motor neurons, with the development of abundant RNA foci but no detectable DPR accumulation [59] .
These results suggest that the potential toxicity of expanded RNA may depend on subcellular localisation and the model system employed. Additionally, no study has attempted to assess the effect of overexpression of antisense RNA in isolation. Thus, further characterisation of existing models as well as development of antisense models will be required to fully assess the contribution of RNA toxicity in C9ALS/FTD.
Protein-only models
Protein-only models include exogenous application of recombinant DPR peptides and the use of codon degeneracy (individual amino acids can be encoded by more than one triplet codon) to generate transgenic models that overexpress individual DPRs in an ATG-driven manner, allowing comparison of their relative effects ( Figure   1G , Table 3 ). Although DPRs may be present at higher levels than those typically observed in patient tissue, there is a broad consensus across multiple model systems that arginine-rich DPRs (poly-GR and Poly-PR) are highly toxic (Table 3) , with other dipeptide proteins, most notably poly-GA, being identified as toxic in some model systems [61, [72] [73] [74] [75] .
In order to determine mechanisms of DPR toxicity, several groups have attempted to identify arginine-DPR interacting proteins using immunoprecipitation of DPRs from cell lines with subsequent mass-spectrometric identification of interacting proteins [76] [77] [78] [79] [80] . Recently, two studies have demonstrated that arginine-rich DPR interactors are enriched in low complexity regions (LCRs), typically found in protein constituents of membrane-less organelles such as stress granules, nuclear speckles and nucleoli [79, 80] . The exact mechanism(s) by which the arginine-rich DPRs are toxic to neurons are still not fully resolved, however translational repression [77, 80] , mitochondrial dysfunction [78] , nucleolar dysfunction [76, 81] , and disruption of nucleocytoplasmic transport have all been implicated [62, 71, 82, 83] .
It should be noted that although poly-GA is seemingly less toxic than the arginine rich DPRs, it has been shown to exert mild toxicity when expressed in Drosophila neurons [61] and in cell culture, including primary rodent neurons [72] [73] [74] [75] . Recently it was demonstrated that AAV-mediated overexpression of poly-GA dipeptides in mice led to neurodegeneration and, cognitive and motor dysfunction [74] . However, only rare TDP-43 inclusions were observed, indicating that accumulation of poly-GA protein alone may be insufficient to lead to the full disease state [74] . Future studies will be required to determine whether arginine-rich DPR overexpression is sufficient to induce ALS/FTD associated phenotypes in mice.
Synergistic Mechanisms
Although researchers have aimed to isolate different possible mechanisms of toxicity in order to elucidate their potential role in disease, it is possible that individual mechanisms act synergistically to induce the disease state.
Whilst loss of function of C9orf72 alone is unlikely to be sufficient to induce disease, cell culture studies suggest that reduced expression of C9orf72 leads to disruption of autophagy [22, 23, 28, 29] and autophagic dysfunction has been strongly linked to neurodegenerative disease [84] . Therefore the potential role of C9orf72 loss of function as a disease modifier should be thoroughly explored. Recently it was demonstrated that overexpression of C9orf72 reduces the aggregation of TDP-43 in cell culture and a small decrease in C9orf72 expression exacerbated expanded ataxin-2 pathology in mouse neurons and zebrafish larvae [23] . The genetic models described above, such as knockout mice and mice transgenic for hexanucleotide expansions can now be combined to ascertain the degree to which C9orf72 loss of function may affect disease phenotypes.
Arginine-rich DPRs are toxic in multiple systems whilst poly-GA has also been shown to be toxic to mouse neurons. Interestingly, poly-GA has been demonstrated to recruit poly-GR into inclusions when co-expressed in human cells [85] and in Drosophila, resulting in a lessening of poly-GR toxicity [86] . Whether interaction between the individual DPRs acts to enhance or suppress their toxicity is thus a point of interest. Additionally, frameshifting during the translation of repetitive proteins has been described in other repeat expansion disorders [87] . Whether this occurs in C9orf72 mutation carriers is currently unknown, but could potentially lead to the production of peptides imbued with the qualities of more than one DPR species.
Conclusions
Recent studies of the mechanism(s) of pathogenesis in C9ALS/FTD have focused on attempting to separate potential pathologies in model systems to study them further.
Although the C9ORF72-L protein has been implicated in the induction of autophagy, a number of mouse loss of function models have failed to develop ALS/FTD associated phenotypes ( Table 1 ). Expression of expanded GGGGCC repeat DNA is extremely toxic in a number of model systems. Recent advances include the expression of GGGGCC repeat DNA in mice, which under some circumstances display motor dysfunction and behavioural abnormalities with TDP-43 pathology ( Table 2 ). Despite the potential shortcomings of the model systems in question, for example the incomplete homology of disrupted orthologous genes (see Table 1 ), or the strong overexpression of relatively short repeat lengths employed in many models, in combination these results strongly indicate that expression of expanded GGGGCC repeats alone are sufficient to cause C9ALS/FTD.
Although it seems likely that the C9orf72 repeat expansions cause toxicity through a gain of function it is not clear whether this is primarily mediated by expanded RNA or DPR proteins. Several groups have attempted to separate RNA expression from DPR production, with clear evidence, albeit in Drosophila models, indicating that repeat RNA without the expression of dipeptide proteins may not be toxic. Others have studied the relative toxicity of different DPR species by overexpressing recodonised protein constructs (Table 3) The hexanucleotide expanded DNA is transcribed in both sense and antisense directions. These expanded RNAs form typically, intranuclear aggregates known as RNA foci, which have been proposed to sequester RNA binding proteins leading to toxicity. C) Repeat expanded RNAs can undergo repeat-associated-non-ATG-initiated (RAN) translation producing repetitive peptides from all reading frames without the requirement of an ATG start codon [57] . RAN translation of both sense and antisense RNA has been demonstrated to occur in C9ALS/FTD patients, leading to the production of five potentially toxic dipeptide repeat proteins (DPRs), these are: poly-glycine-alanine (poly-GA), poly-glycine-proline (poly-GP), poly-glycine-arginine (poly-GR), poly-alanine-proline (poly-AP), and poly-proline-arginine (poly-PR). D) Loss of function of C9orf72 or its orthologous genes in other species can be used to study whether a complete or partial loss of C9orf72 in isolation is sufficient to induce a disease phenotype (see Table 1 ) E) Transgenic overexpression of GGGGCC repeats, either on their own or as part of a patient derived bacterial artificial chromosome (BAC), model both RNA and DPR toxicity, an approach that has recently been applied to generate mouse models of the disease ( Table 2 ). F) Two approaches have been used to suppress RAN translation and study the effect of hexanucleotide repeat expression in isolation, either expression of relatively short stretches of GGGGCC repeats from within a strongly constitutively spliced intronic region [59, 70] or by regularly interrupting the repeat sequence with stop codons [61] . G) Codon degeneracy allows for the engineering of "recodonised" constructs that allow ATG-initiated expression of individual dipeptide repeat proteins without an underlying GGGGCC repeat sequence (Table 3) . No motor abnormalities in any tested line. Male but not female medium and high 450 repeat expressors display cognitive and behavioural dysfunction.
Foci Pathology Dipeptide Pathology
Male and female mice examined. Either acute phenotype, slower progressive phenotype (symptomatic mice), or asymptomatic. Acute phenotype characterised by reduced survival. Symptomatic mice display behavioural and motor abnormalities.
FVB/NJ C57BL/6J Table 3 : Comparison of studies that compare the toxicity of individual DPRs in different model systems.
Numbers indicate the repeat length(s) tested in the study, note: in some studies the dipeptide proteins are epitope tagged. *Peptides were exogenously applied to cells rather than overexpressed. Note poly-GA was found to be toxic in primary neurons [72] [73] [74] [75] but these studies were excluded from the table as they do not compare to other DPRs.
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